Increased enzymatic activity of the T-cell antigen receptor-associated Fyn protein tyrosine kinase in asymptomatic patients infected with the human immunodeficiency virus

Blood

Volumn 90, Issue 9, 1997, Pages 3603-3612

  Phipps, David J ^b   Yousefi, Shida ^b   Branch, Donald R ^a  

^a Canadian Red Cross Society   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; PHOSPHORYLATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0030836298     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3603     Document Type: Article

References (47)

1. Ascher MS, Sheppard HW: AIDS as immune system activation. II. The panergic imnesia hypothesis. J Acquir Immune Defic Syndr 3:177, 1990
2. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H: Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today 9:150, 1988
3. Sadat-Sowti B, Debre P: Cytokines and HIV infection. Eur. Cytokine Network 3:515, 1992
4. Godfried MH, van der Poll T, Weverling GJ, Mulder JW, Jansen J, van Deventer SJ, Sauerwein HP: Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 169:739, 1994
5. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322:166, 1990
6. Samelson LE, Phillips AF, Luong ET, Klausner RD: Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc Natl Acad Sci USA 87:4358, 1990
7. fyn). Cell 65:281, 1991
8. fyn. J Exp Med 175:1483, 1992
9. lck. Cell 55:301, 1988
10. fyn mutant mice display differential signalling in thymocytes and peripheral T cells. Cell 70:741, 1992
11. fyn. Cell 70:751, 1992
12. lck. Nature 357:161, 1992
13. lck with CD4 in human T lymphocytes. J Biol Chem 266:11176, 1991
14. lck in human CD4 T lymphocytes. Eur J Immunol 23:600, 1993
15. Phipps DJ, Reed-Doob P, Macfadden DK, Piovesan JP, Mills GB, Branch DR: An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytes. Clin Exp Immunol 100:412, 1995
16. lck, a lymphocyte specific protein tyrosine kinase, on the syncytium formation induced by human immunodeficiency virus envelope glycoprotein. Int Immunol 4:233, 1992
17. lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J 13:774, 1994
18. lck. J Exp Med 183:39, 1996
19. Cohen DI, Tani Y, Tian H, Boone E, Samelson LE, Lane HC: Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science 256:542, 1992
20. Phipps DJ, Road SE, Piovesan JP, Mills GB, Branch DR: HIV infection in vitro enhances the activity of src-family protein tyrosine kinases. AIDS 10:1191, 1996
21. Mills GB, Arima N, May C, Hill M, Sehmandt R, Li J, Miyamoto NG, Greene WC: Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transuction in HTLV-I-infected human T cells. Int Immunol 4:1233, 1992
22. c-src expression is induced by activation of normal human T lymphocytes. J Immunol 154:3678, 1995
23. Mills GB, Schmundt R, Gibson S, Leung B, Hill M, May C, Shi YF, Branch DR, Radvanyi L, Truitt KF, Imboden J: Transmembrane signaling by the interleukin-2 receptor: progress and conundrums. Semin Immunol 5:345, 1993
24. Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon H-U: Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in freshly isolated eosinophils. J Exp Med 183:1407, 1996
25. Cooper JA, Hunter T: Identification and characterization of cellular targets for tyrosine protein kinases. J Biol Chem 258:1108, 1983
26. c-src. Nature 349:172, 1991
27. Gibson S, August A, Branch D, Dupont B, Mills GB: Functional LCK is required for optimal CD28-mediated activation of the TEC family tyrosine kinase EMT/ITK. J Biol Chem 271:7079, 1996
28. c-src family of protein-tyrosine kinases: Structure, regulation, and function. Crit Rev Oncogene 3:401, 1992
29. Imamoto A, Soriano P: Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73:1117, 1993
30. Nada S, Yagi T, Takeda H, Tokunaga T, Nakagawa H, Ikawa Y, Okada M, Aizawa S: Constitutive activation of src family kinases in mouse embryos that lack csk. Cell 73:1125, 1993
31. Brizuela L, Ulug ET, Jones MA, Courtneidge SA: Induction of interleukin-2 transcription by the hamster polyomavirus middle T antigen: A role for Fyn in T cell signal transduction. Eur J Immunol 25:385, 1995
32. fyn and ZAP-70, in T cell signaling. J Immunol 156:1369, 1996
33. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw CM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117, 1995
34. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123, 1995
35. Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749, 1993
36. Hurley TR, Hyman R, Sefton BM: Differential effects of expression of the CD45 tyrosine protein phosphataase on the tyrosine phosphorylation of the lck, fyn, and c-src tyrosine protein kinases. Mol Cell Biol 13:1651, 1993
37. Fang KS, Sabe H, Saito H, Hanafusa H: Comparative study of three protein-tyrosine phosphatases: Chicken protein-tyrosine phosphatase lambda dephosphorylates e-Src tyrosine 527. J Biol Chem 269:20194, 1994
38. lck in CD4 T cells from HIV-1 infected patients. Int Immunol 6:611, 1994
39. Pinching AJ, Nye KE: Defective signal iransduction - A common pathway for cellular dysfunction in HIV infection? Immunol Today 11:256, 1990
40. Shearer CM, Bernstein DC, Tung KS, Via CS, Redfield R, Salahuddin SZ, Gallo RC: A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 137:2514, 1986
41. Clerici M, Stocks NI, Zajac RA, Boswell RN, Bernstein DC, Mann DL, Shearer GM, Berzofsky JA: Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 339:383, 1989
42. + memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 87:6058, 1990
43. Meyaard L, Miedema F: Programmed death of T cells in HIV infection: Result of immune activation? Curr Top Micro Immunol 200:213, 1995
44. Newell MK, Haughn LJ, Maroun CR, Julius MH: Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 347:286, 1990
45. Radvanyi LG, Mills GB, Miller RG: Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol 150:5704, 1993
46. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370:463, 1994
47. Livingstone WJ, Moore M, Innes D, Bell JE, Simmpnds P: Frequent infection of peripheral blood CDS-positive T-lymphocytes with HIV-1. Lancet 348:649, 1996